Patents by Inventor Hirotaka KAWANABE

Hirotaka KAWANABE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITION FOR ENHANCING IMMUNE CHECKPOINT BLOCKADE THERAPY
    Publication number: 20230390348
    Abstract: The object of the invention is to provide a composition for enhancing an immune checkpoint blockade therapy. A composition forenhancing an immune checkpoint blockade therapy, which contains an exopolysaccharide of a lactic acid bacterium is provided. Preferred examples of the lactic acid bacterium include Lactobacillus bacteria (especially Lactobacillus delbrueckii subsp. bulgaricus OLL1073 R-1).
    Type: Application
    Filed: August 21, 2023
    Publication date: December 7, 2023
    Applicant: MEIJI CO., LTD.
    Inventors: Hirotaka KAWANABE, Marie NAKAMURA
  • Composition for enhancing immune checkpoint blockade therapy
    Patent number: 11759485
    Abstract: The object of the invention is to provide a composition for enhancing an immune checkpoint blockade therapy. A composition for enhancing an immune checkpoint blockade therapy, which contains an exopolysaccharide of a lactic acid bacterium is provided. Preferred examples of the lactic acid bacterium include Lactobacillus bacteria (especially Lactobacillus delbrueckii subsp. bulgaricus OLL1073 R-1).
    Type: Grant
    Filed: June 13, 2019
    Date of Patent: September 19, 2023
    Assignee: MEIJI CO., LTD.
    Inventors: Hirotaka Kawanabe, Marie Nakamura
  • Fermented milk and polysaccharide with cancerous cachexia inhibitory effect
    Patent number: 11638431
    Abstract: An object of the present invention is to provide a fermented milk and polysaccharide capable of inhibiting cancerous cachexia. A fermented milk with cancerous cachexia inhibitory effect according to one aspect of the present invention contains Lactobacillus delbrueckii subsp. bulgaricus as an active ingredient. Also, polysaccharide with cancerous cachexia inhibitory effect according to another aspect of the present invention are produced from the Lactobacillus delbrueckii subsp. bulgaricus. It is preferable that the Lactobacillus delbrueckii subsp. bulgaricus is Lactobacillus delbrueckii subsp. bulgaricus OLL1073R-1 (accession number: FERM BP-10741).
    Type: Grant
    Filed: October 29, 2018
    Date of Patent: May 2, 2023
    Assignee: MEIJI CO., LTD.
    Inventors: Hirotaka Kawanabe, Marie Nakamura
  • A COMPOSITION FOR ENHANCING IMMUNE CHECKPOINT BLOCKADE THERAPY
    Publication number: 20210213077
    Abstract: The object of the invention is to provide a composition for enhancing an immune checkpoint blockade therapy. A composition forenhancing an immune checkpoint blockade therapy, which contains an exopolysaccharide of a lactic acid bacterium is provided. Preferred examples of the lactic acid bacterium include Lactobacillus bacteria (especially Lactobacillus delbrueckii subsp. bulgaricus OLL1073 R-1).
    Type: Application
    Filed: June 13, 2019
    Publication date: July 15, 2021
    Applicant: MEIJI CO., LTD.
    Inventors: Hirotaka KAWANABE, Marie NAKAMURA
  • FERMENTED MILK AND POLYSACCHARIDE WITH CANCEROUS CACHEXIA INHIBITORY EFFECT
    Publication number: 20200296979
    Abstract: An object of the present invention is to provide a fermented milk and polysaccharide capable of inhibiting cancerous cachexia. A fermented milk with cancerous cachexia inhibitory effect according to one aspect of the present invention contains Lactobacillus delbrueckii subsp. bulgaricus as an active ingredient. Also, polysaccharide with cancerous cachexia inhibitory effect according to another aspect of the present invention are produced from the Lactobacillus delbrueckii subsp. bulgaricus. It is preferable that the Lactobacillus delbrueckii subsp. bulgaricus is Lactobacillus delbrueckii subsp. bulgaricus OLL1073R-1 (accession number: FERM BP-10741).
    Type: Application
    Filed: October 29, 2018
    Publication date: September 24, 2020
    Applicant: MEIJI CO., LTD.
    Inventors: Hirotaka KAWANABE, Marie NAKAMURA